Lantz Financial LLC lessened its stake in CME Group Inc. (NASDAQ:CME – Free Report) by 1.9% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,755 shares of the financial services provider’s stock after selling 92 shares during the quarter. Lantz Financial LLC’s holdings in CME Group were worth $881,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors also recently modified their holdings of the company. MayTech Global Investments LLC bought a new stake in shares of CME Group during the fourth quarter valued at approximately $25,000. GW&K Investment Management LLC lifted its holdings in CME Group by 153.3% in the fourth quarter. GW&K Investment Management LLC now owns 152 shares of the financial services provider’s stock valued at $26,000 after buying an additional 92 shares during the period. CoreCap Advisors LLC acquired a new position in CME Group in the fourth quarter valued at approximately $26,000. Power Corp of Canada acquired a new position in CME Group in the first quarter valued at approximately $26,000. Finally, Silicon Valley Capital Partners acquired a new position in CME Group in the first quarter valued at approximately $27,000. 85.69% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
Several brokerages recently weighed in on CME. Citigroup increased their price objective on shares of CME Group from $210.00 to $215.00 and gave the company a “buy” rating in a report on Thursday, July 27th. Bank of America upgraded shares of CME Group from an “underperform” rating to a “neutral” rating and increased their price objective for the company from $167.00 to $204.00 in a report on Wednesday, September 6th. Barclays increased their price objective on shares of CME Group from $215.00 to $230.00 and gave the company an “overweight” rating in a report on Thursday, July 27th. Rosenblatt Securities increased their price objective on shares of CME Group from $169.00 to $173.00 and gave the company a “sell” rating in a report on Thursday, July 27th. Finally, StockNews.com assumed coverage on shares of CME Group in a report on Thursday, August 17th. They issued a “hold” rating on the stock. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $211.00.
Insider Buying and Selling
In related news, Director Daniel R. Glickman sold 750 shares of the firm’s stock in a transaction on Wednesday, August 9th. The shares were sold at an average price of $206.09, for a total transaction of $154,567.50. Following the sale, the director now directly owns 14,658 shares in the company, valued at $3,020,867.22. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In related news, Director Daniel R. Glickman sold 750 shares of the firm’s stock in a transaction on Wednesday, August 9th. The shares were sold at an average price of $206.09, for a total value of $154,567.50. Following the completion of the transaction, the director now owns 14,658 shares of the company’s stock, valued at $3,020,867.22. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO Terrence A. Duffy sold 30,000 shares of the firm’s stock in a transaction on Friday, August 18th. The shares were sold at an average price of $203.95, for a total transaction of $6,118,500.00. Following the completion of the transaction, the chief executive officer now directly owns 65,545 shares of the company’s stock, valued at approximately $13,367,902.75. The disclosure for this sale can be found here. Insiders have sold a total of 58,391 shares of company stock worth $11,905,049 over the last ninety days. Company insiders own 0.30% of the company’s stock.
CME Group Stock Up 0.4 %
Shares of NASDAQ:CME traded up $0.86 during midday trading on Tuesday, reaching $207.41. 101,685 shares of the company were exchanged, compared to its average volume of 1,584,118. CME Group Inc. has a fifty-two week low of $166.54 and a fifty-two week high of $209.31. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. The stock has a fifty day simple moving average of $199.29 and a two-hundred day simple moving average of $189.75. The firm has a market cap of $74.62 billion, a PE ratio of 25.22, a P/E/G ratio of 2.69 and a beta of 0.41.
CME Group (NASDAQ:CME – Get Free Report) last issued its quarterly earnings data on Wednesday, July 26th. The financial services provider reported $2.30 EPS for the quarter, topping analysts’ consensus estimates of $2.20 by $0.10. CME Group had a net margin of 56.88% and a return on equity of 11.30%. The business had revenue of $1.36 billion for the quarter, compared to analyst estimates of $1.34 billion. During the same period last year, the business posted $1.97 earnings per share. The firm’s quarterly revenue was up 9.9% on a year-over-year basis. As a group, sell-side analysts forecast that CME Group Inc. will post 9.02 earnings per share for the current year.
CME Group Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 27th. Investors of record on Friday, September 8th will be issued a dividend of $1.10 per share. The ex-dividend date of this dividend is Thursday, September 7th. This represents a $4.40 dividend on an annualized basis and a dividend yield of 2.12%. CME Group’s payout ratio is 53.72%.
CME Group Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
- Five stocks we like better than CME Group
- Stock Market Sectors: What Are They and How Many Are There?
- 2 Beauty Stocks Beaten By the Ugly Stick But Ready to Rally
- What are stock market earnings reports?
- Got Nuclear? Three Stocks To Play Energy’s Next Frontier
- What is Forex and How Does it Work?
- The Top 4 Utilities for Value, Yield, and Upside Potential
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.